ALNOV:EPA
Novacyt SA
0,43 €
arrow_upward
+0,12%(+0,00050) 1D
18. stu, 17:11:42 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALNOV...
Otvori
0,44 €
Najviša
0,44 €
Najniža
0,43 €
Trž. kap.
31,89 mil.
Prosj. kol.
139,48 tis.
Količina
133,51 tis.
52-tjed. najviša
1,04 €
52-tjed. najniža
0,29 €
EPS
−0,38 €
Dionice u optjecaju
72,59 mil.
Broj djelatnika
228
Otvori
0,44 €
Najviša
0,44 €
Najniža
0,43 €
Trž. kap.
31,89 mil.
Prosj. kol.
139,48 tis.
Količina
133,51 tis.
52-tjed. najviša
1,04 €
52-tjed. najniža
0,29 €
EPS
−0,38 €
Dionice u optjecaju
72,59 mil.
Broj djelatnika
228
Vijesti
Iz web-izvora i od partnera za vijesti
ChartMill
·
prije 1 sat
S&P 500 Gap-Down Movers for Nov. 18 Session
Kitco
·
prije 34 minute
S&P 500, Nasdaq open higher as Nvidia forecast eases AI jitters
Coinpaper
·
prije 1 sat
Dow Jones: Wall Street Eyes Rebound as Morgan Stanley Targets S&P 500 at 8,700
Proactive financial news
·
prije 30 minuta
MARKETS LIVE: Dow losses deepen and S&P 500 turns lower as gold slides
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA – informacije
Glavni izvršni direktorDavid Allmond
Zaposlenici228
Osnovano3. srp 2006.
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijanovacyt.com